» Articles » PMID: 37415660

The Value of Conventional Ultrasound Combined with Superb Microvascular Imaging and Color Doppler Flow Imaging in the Diagnosis of Thyroid Malignant Nodules: a Systematic Review and Meta-analysis

Overview
Specialty Endocrinology
Date 2023 Jul 7
PMID 37415660
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate and compare the value of conventional ultrasound-based superb microvascular imaging (SMI) and color Doppler flow imaging (CDFI) in the diagnosis of malignant thyroid nodule by meta-analysis.

Methods: The literature included in the Cochrane Library, PubMed, and Embase were searched by using " superb microvascular imaging (SMI), color Doppler flow imaging (CDFI), ultrasound, thyroid nodules" as the keywords from inception through February 1, 2023. According to the inclusion and exclusion criteria, the clinical studies using SMI and CDFI to diagnose thyroid nodules were selected, and histopathology of thyroid nodules was used as reference standard. The diagnostic accuracy research quality assessment tool (QUADAS-2) was used to evaluate the quality of included literature, and the Review Manager 5.4 was used to make the quality evaluation chart. The heterogeneity test was performed on the literature that met the requirements, the combined sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio were pooled, and a comprehensive ROC curve analysis was performed. Meta-DiSc version 1.4, StataSE 12, and Review Manager 5.4 software were used.

Results: Finally, 13 studies were included in this meta-analysis. A total of 815 thyroid malignant nodules were assessed. All thyroid nodules were histologically confirmed after SMI or CDFI. The combined sensitivity, specificity, PLR, NLR, DOR, and area under the SROC curve of SMI for the diagnosis of malignant thyroid nodules were 0.80(95%CI: 0.77-0.83), 0.79(95%CI: 0.77-0.82), 4.37(95%CI: 3.0-6.36), 0.23(95%CI: 0.15-0.35), 22.29(95%CI: 12.18-40.78), and 0.8944, respectively; the corresponding values of CDFI were 0.62(95%CI: 0.57-0.67), 0.81(95%CI: 0.78-0.85), 3.33(95%CI: 2.18-5.07), 0.41(95%CI: 0.27-0.64), 8.93(95%CI: 3.96-20.16), and 0.8498. Deek funnel pattern showed no significant publication bias.

Conclusion: The diagnostic efficiency of SMI for malignant thyroid nodules is better than CDFI, and SMI technology can provide significantly more information on vascularity, make up for the deficiency of CDFI, and has better clinical application value.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42023402064.

Citing Articles

Diagnostic value of greyscale ultrasound combined with superb microvascular imaging in thyroid nodules: a systematic review and meta-analysis.

Li W, Ge Z, Cai S, Fang S, Zhang M, Wang H Quant Imaging Med Surg. 2025; 15(1):440-454.

PMID: 39839006 PMC: 11744117. DOI: 10.21037/qims-24-1195.


Application of microvascular ultrasound-assisted thyroid imaging report and data system in thyroid nodule risk stratification.

Ma G, Chen L, Wang Y, Luo Z, Zeng Y, Wang X Insights Imaging. 2024; 15(1):230.

PMID: 39311997 PMC: 11420409. DOI: 10.1186/s13244-024-01806-5.


Significance of maximum intensity projection technique of multimodal ultrasound imaging in differentiating follicular thyroid carcinoma from benign lesions.

Gao W, Chen Y, Wu Q, Li Y, Zheng Y, Wang Y Front Oncol. 2024; 14:1407611.

PMID: 39301550 PMC: 11410567. DOI: 10.3389/fonc.2024.1407611.


Quantitative ultrasound imaging parameters in patients with cancerous thyroid nodules: development of a diagnostic model.

Liu M, Pan N Am J Transl Res. 2024; 16(6):2645-2653.

PMID: 39006293 PMC: 11236663. DOI: 10.62347/WEDG9279.


Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Various Pathological Types.

Xu Y, Pi J, Jinghu Y, Wang X, Xu D, Liu J Med Sci Monit. 2024; 30:e943228.

PMID: 38764217 PMC: 11119926. DOI: 10.12659/MSM.943228.


References
1.
Egset A, Holm C, Larsen S, Nielsen S, Bach J, Helweg-Larsen J . Risk of malignancy in fine-needle aspiration biopsy in patients with thyroid nodules. Dan Med J. 2017; 64(2). View

2.
Hornung M, Jung E, Georgieva M, Schlitt H, Stroszczynski C, Agha A . Detection of microvascularization of thyroid carcinomas using linear high resolution contrast-enhanced ultrasonography (CEUS). Clin Hemorheol Microcirc. 2012; 52(2-4):197-203. DOI: 10.3233/CH-2012-1597. View

3.
Dubinsky T, Revels J, Wang S, Toia G, Sonneborn R, Hippe D . Comparison of Superb Microvascular Imaging With Color Flow and Power Doppler Imaging of Small Hepatocellular Carcinomas. J Ultrasound Med. 2018; 37(12):2915-2924. DOI: 10.1002/jum.14654. View

4.
Durante C, Grani G, Lamartina L, Filetti S, Mandel S, Cooper D . The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018; 319(9):914-924. DOI: 10.1001/jama.2018.0898. View

5.
Cappelli C, Pirola I, Gandossi E, Marini F, Cristiano A, Casella C . Ultrasound Microvascular Blood Flow Evaluation: A New Tool for the Management of Thyroid Nodule?. Int J Endocrinol. 2019; 2019:7874890. PMC: 6452547. DOI: 10.1155/2019/7874890. View